These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 28664165)
1. Clearance of Heparan Sulfate and Attenuation of CNS Pathology by Intracerebroventricular BMN 250 in Sanfilippo Type B Mice. Aoyagi-Scharber M; Crippen-Harmon D; Lawrence R; Vincelette J; Yogalingam G; Prill H; Yip BK; Baridon B; Vitelli C; Lee A; Gorostiza O; Adintori EG; Minto WC; Van Vleet JL; Yates B; Rigney S; Christianson TM; Tiger PMN; Lo MJ; Holtzinger J; Fitzpatrick PA; LeBowitz JH; Bullens S; Crawford BE; Bunting S Mol Ther Methods Clin Dev; 2017 Sep; 6():43-53. PubMed ID: 28664165 [TBL] [Abstract][Full Text] [Related]
2. BMN 250, a fusion of lysosomal alpha-N-acetylglucosaminidase with IGF2, exhibits different patterns of cellular uptake into critical cell types of Sanfilippo syndrome B disease pathogenesis. Yogalingam G; Luu AR; Prill H; Lo MJ; Yip B; Holtzinger J; Christianson T; Aoyagi-Scharber M; Lawrence R; Crawford BE; LeBowitz JH PLoS One; 2019; 14(1):e0207836. PubMed ID: 30657762 [TBL] [Abstract][Full Text] [Related]
3. Differential Uptake of NAGLU-IGF2 and Unmodified NAGLU in Cellular Models of Sanfilippo Syndrome Type B. Prill H; Luu A; Yip B; Holtzinger J; Lo MJ; Christianson TM; Yogalingam G; Aoyagi-Scharber M; LeBowitz JH; Crawford BE; Lawrence R Mol Ther Methods Clin Dev; 2019 Sep; 14():56-63. PubMed ID: 31309128 [TBL] [Abstract][Full Text] [Related]
4. Biochemical evaluation of intracerebroventricular rhNAGLU-IGF2 enzyme replacement therapy in neonatal mice with Sanfilippo B syndrome. Kan SH; Elsharkawi I; Le SQ; Prill H; Mangini L; Cooper JD; Lawrence R; Sands MS; Crawford BE; Dickson PI Mol Genet Metab; 2021 Jun; 133(2):185-192. PubMed ID: 33839004 [TBL] [Abstract][Full Text] [Related]
5. Translational studies of intravenous and intracerebroventricular routes of administration for CNS cellular biodistribution for BMN 250, an enzyme replacement therapy for the treatment of Sanfilippo type B. Grover A; Crippen-Harmon D; Nave L; Vincelette J; Wait JCM; Melton AC; Lawrence R; Brown JR; Webster KA; Yip BK; Baridon B; Vitelli C; Rigney S; Christianson TM; Tiger PMN; Lo MJ; Holtzinger J; Shaywitz AJ; Crawford BE; Fitzpatrick PA; LeBowitz JH; Bullens S; Aoyagi-Scharber M; Bunting S; O'Neill CA; Pinkstaff J; Bagri A Drug Deliv Transl Res; 2020 Apr; 10(2):425-439. PubMed ID: 31942701 [TBL] [Abstract][Full Text] [Related]
11. Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum. Cressant A; Desmaris N; Verot L; Bréjot T; Froissart R; Vanier MT; Maire I; Heard JM J Neurosci; 2004 Nov; 24(45):10229-39. PubMed ID: 15537895 [TBL] [Abstract][Full Text] [Related]
12. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient. Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744 [TBL] [Abstract][Full Text] [Related]
13. Brain transplantation of genetically corrected Sanfilippo type B neural stem cells induces partial cross-correction of the disease. Pearse Y; Clarke D; Kan SH; Le SQ; Sanghez V; Luzzi A; Pham I; Nih LR; Cooper JD; Dickson PI; Iacovino M Mol Ther Methods Clin Dev; 2022 Dec; 27():452-463. PubMed ID: 36419468 [TBL] [Abstract][Full Text] [Related]
14. EGFR activation triggers cellular hypertrophy and lysosomal disease in NAGLU-depleted cardiomyoblasts, mimicking the hallmarks of mucopolysaccharidosis IIIB. De Pasquale V; Pezone A; Sarogni P; Tramontano A; Schiattarella GG; Avvedimento VE; Paladino S; Pavone LM Cell Death Dis; 2018 Jan; 9(2):40. PubMed ID: 29348482 [TBL] [Abstract][Full Text] [Related]
15. [Postnatal and prenatal diagnosis of mucopolysaccharidosis type III (Sanfilippo syndrome)]. Zhang WM; Shi HP; Meng Y; Li BT; Qiu ZQ; Liu JT Zhonghua Er Ke Za Zhi; 2008 Jun; 46(6):407-10. PubMed ID: 19099774 [TBL] [Abstract][Full Text] [Related]
16. Disease correction in mucopolysaccharidosis type IIIB mice by intraparenchymal or cisternal delivery of a capsid modified AAV8 codon-optimized NAGLU vector. Rouse CJ; Hawkins K; Kabbej N; Dalugdug J; Kunta A; Kim MJ; Someya S; Herbst Z; Gelb M; Dinelli I; Butterworth E; Falk DJ; Rosenkrantz E; Elmohd H; Khaledi H; Mowafy S; Ashby F; Heldermon CD Hum Mol Genet; 2023 Jan; 32(3):417-430. PubMed ID: 35997776 [TBL] [Abstract][Full Text] [Related]
17. Insulin Receptor Antibody-α-N-Acetylglucosaminidase Fusion Protein Penetrates the Primate Blood-Brain Barrier and Reduces Glycosoaminoglycans in Sanfilippo Type B Fibroblasts. Boado RJ; Lu JZ; Hui EK; Lin H; Pardridge WM Mol Pharm; 2016 Apr; 13(4):1385-92. PubMed ID: 26910785 [TBL] [Abstract][Full Text] [Related]
18. Trehalose reduces retinal degeneration, neuroinflammation and storage burden caused by a lysosomal hydrolase deficiency. Lotfi P; Tse DY; Di Ronza A; Seymour ML; Martano G; Cooper JD; Pereira FA; Passafaro M; Wu SM; Sardiello M Autophagy; 2018; 14(8):1419-1434. PubMed ID: 29916295 [TBL] [Abstract][Full Text] [Related]
19. The Murine Model of Mucopolysaccharidosis IIIB Develops Cardiopathies over Time Leading to Heart Failure. Schiattarella GG; Cerulo G; De Pasquale V; Cocchiaro P; Paciello O; Avallone L; Belfiore MP; Iacobellis F; Di Napoli D; Magliulo F; Perrino C; Trimarco B; Esposito G; Di Natale P; Pavone LM PLoS One; 2015; 10(7):e0131662. PubMed ID: 26147524 [TBL] [Abstract][Full Text] [Related]
20. Retrovirally transduced bone marrow has a therapeutic effect on brain in the mouse model of mucopolysaccharidosis IIIB. Zheng Y; Ryazantsev S; Ohmi K; Zhao HZ; Rozengurt N; Kohn DB; Neufeld EF Mol Genet Metab; 2004 Aug; 82(4):286-95. PubMed ID: 15308126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]